22,335
edits
Changes
Jump to navigation
Jump to search
Created page with "{{Construction Site}} right|thumb| Apligraf is a synthetic skin created from harvested foreskins.<ref> {{cite web | url = http://www.apligraf.com..."
{{Construction Site}}
[[Image:Alloderm-logo.jpg|right|thumb|]]
Apligraf is a synthetic skin created from harvested foreskins.<ref>
{{cite web
| url = http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
| title = Apligraf: How Is It Made?
| accessdate = 2011-03-06
| publisher = Organogenesis
| quote = Human keratinocytes and fibroblasts are derived from neonatal foreskins
}}
</ref> It is [[FDA]] approved,<ref>
{{cite web
| url = http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
| title = Apligraf
| accessdate = 2011-03-06
| publisher = Organogenesis
| quote = Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
}}
</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
==Apligraph Oral==
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref> {{cite web | url = http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | title = November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | accessdate = 2011-12-20 | date = November 2011}}</ref>
Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf
==<small>References</small>==
<div class='references-small'>
<references/>
</div>
[[Category:Foreskin Products]]
[[Category:Financial Gain]]
[[Category:CircLeaks]]
[[Category:Construction Site]]
[[Category:From IntactWiki]]
[[Image:Alloderm-logo.jpg|right|thumb|]]
Apligraf is a synthetic skin created from harvested foreskins.<ref>
{{cite web
| url = http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
| title = Apligraf: How Is It Made?
| accessdate = 2011-03-06
| publisher = Organogenesis
| quote = Human keratinocytes and fibroblasts are derived from neonatal foreskins
}}
</ref> It is [[FDA]] approved,<ref>
{{cite web
| url = http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
| title = Apligraf
| accessdate = 2011-03-06
| publisher = Organogenesis
| quote = Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
}}
</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
==Apligraph Oral==
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref> {{cite web | url = http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | title = November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | accessdate = 2011-12-20 | date = November 2011}}</ref>
Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf
==<small>References</small>==
<div class='references-small'>
<references/>
</div>
[[Category:Foreskin Products]]
[[Category:Financial Gain]]
[[Category:CircLeaks]]
[[Category:Construction Site]]
[[Category:From IntactWiki]]